Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management.
J Louise JonesAndrew M HanbyClive WellsMarie CalaminiciLaura JohnsonPhilip TurtonRahul DebElena ProvenzanoAbeer ShaabanIan O EllisSarah E Pindernull nullPublished in: Histopathology (2019)
BIA-ALCL is a rare but important complication of breast implants. While characterised by CD30-positive neoplastic cells this must be interpreted with care, and we provide pathological guidelines for the robust diagnosis of this lesion as well as the most appropriate staging system and management strategies. Finally, in order to generate more accurate data on incidence, we recommend mechanisms for the routine central reporting of all cases.
Keyphrases
- clinical practice
- induced apoptosis
- healthcare
- soft tissue
- cell cycle arrest
- single cell
- palliative care
- diffuse large b cell lymphoma
- lymph node
- risk factors
- cell therapy
- electronic health record
- quality improvement
- high resolution
- endoplasmic reticulum stress
- adverse drug
- pet ct
- emergency department
- pain management
- oxidative stress
- signaling pathway
- cell death
- bone marrow
- nk cells
- artificial intelligence
- health insurance